NYSE American - Delayed Quote USD

Xtant Medical Holdings, Inc. (XTNT)

0.8372 +0.0528 (+6.73%)
At close: April 18 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
91,303.0000
91,303.0000
57,969.0000
55,263.0000
53,337.0000
Cost of Revenue
35,836.0000
35,836.0000
25,832.0000
22,773.0000
18,945.0000
Gross Profit
55,467.0000
55,467.0000
32,137.0000
32,490.0000
34,392.0000
Operating Expense
65,625.0000
65,625.0000
38,892.0000
36,344.0000
35,143.0000
Operating Income
-10,158.0000
-10,158.0000
-6,755.0000
-3,854.0000
-751.0000
Net Non Operating Interest Income Expense
-2,789.0000
-2,789.0000
-1,661.0000
-995.0000
-5,976.0000
Other Income Expense
11,910.0000
11,910.0000
--
--
--
Pretax Income
-1,037.0000
-1,037.0000
-8,416.0000
-4,849.0000
-6,727.0000
Tax Provision
-1,697.0000
-1,697.0000
69.0000
--
296.0000
Net Income Common Stockholders
660.0000
660.0000
-8,485.0000
-4,849.0000
-7,023.0000
Diluted NI Available to Com Stockholders
660.0000
660.0000
-8,485.0000
-4,849.0000
-7,023.0000
Basic EPS
0.02
0.01
-0.09
-0.06
-0.25
Diluted EPS
0.02
0.01
-0.09
-0.06
-0.25
Basic Average Shares
113,693.1670
119,093.6870
94,085.1970
85,456.1750
28,499.8470
Diluted Average Shares
120,031.8740
126,793.3180
94,085.1970
85,456.1750
28,499.8470
Total Operating Income as Reported
-10,158.0000
-10,158.0000
-6,755.0000
-3,854.0000
-751.0000
Total Expenses
101,461.0000
101,461.0000
64,724.0000
59,117.0000
54,088.0000
Net Income from Continuing & Discontinued Operation
660.0000
660.0000
-8,485.0000
-4,849.0000
-7,023.0000
Normalized Income
-8,787.6100
-8,787.6100
-8,485.0000
-4,849.0000
-7,023.0000
Interest Income
149.0000
149.0000
31.0000
--
--
Interest Expense
2,938.0000
2,938.0000
1,692.0000
995.0000
5,976.0000
Net Interest Income
-2,789.0000
-2,789.0000
-1,661.0000
-995.0000
-5,976.0000
EBIT
1,901.0000
1,901.0000
-6,724.0000
-3,854.0000
-751.0000
EBITDA
5,075.0000
5,075.0000
-5,432.0000
-2,522.0000
1,328.0000
Reconciled Cost of Revenue
35,836.0000
35,836.0000
25,832.0000
22,773.0000
18,945.0000
Reconciled Depreciation
3,174.0000
3,174.0000
1,292.0000
1,332.0000
2,079.0000
Net Income from Continuing Operation Net Minority Interest
660.0000
660.0000
-8,485.0000
-4,849.0000
-7,023.0000
Total Unusual Items Excluding Goodwill
11,959.0000
11,959.0000
--
--
--
Total Unusual Items
11,959.0000
11,959.0000
--
--
--
Normalized EBITDA
-6,884.0000
-6,884.0000
-5,432.0000
-2,522.0000
1,328.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
--
0.0003
Tax Effect of Unusual Items
2,511.3900
2,511.3900
--
--
--
12/31/2020 - 7/1/2010
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

ATEC Alphatec Holdings, Inc.
12.34
-1.36%
 
CYDX CYduct Diagnostics, Inc.
0.3000
0.00%
 
BVS Bioventus Inc.
4.5500
-3.19%
 
OFIX Orthofix Medical Inc.
13.02
+0.15%
 
SNWV SANUWAVE Health, Inc.
0.0239
-0.62%
 
ECOR electroCore, Inc.
5.64
+0.36%
 
ELUT Elutia Inc.
3.0500
+2.87%
 
SRDX Surmodics, Inc.
26.39
-0.49%
 
SNN Smith & Nephew plc
24.01
+0.38%
 
VREX Varex Imaging Corporation
16.92
+0.06%